New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Early clinical trial data show gene therapy reversing sickle cell anemia

Early clinical trial data show gene therapy reversing sickle cell anemia

by Cincinnati Children's Hospital Medical CenterTechnicians work in the ISO-certified cleanroom laboratory at Cincinnati Children's, where gene-correction therapies are tested and produce
Oncology April 20,2024
Early clinical trial data show gene therapy reversing sickle cell anemia

Early clinical trial data show gene therapy reversing sickle cell anemia

by Cincinnati Children's Hospital Medical CenterTechnicians work in the ISO-certified cleanroom laboratory at Cincinnati Children's, where gene-correction therapies are tested and produce
Oncology April 20,2024
Incidence of early-stage breast CA, CRC up with ACA adoption

Incidence of early-stage breast CA, CRC up with ACA adoption

(HealthDay)—After adoption of the Affordable Care Act (ACA), there was an increase in the incidence of early-stage breast and colorectal cancer, according to a research letter published online Nov. 2
Oncology April 20,2024
Incidence of early-stage breast CA, CRC up with ACA adoption

Incidence of early-stage breast CA, CRC up with ACA adoption

(HealthDay)—After adoption of the Affordable Care Act (ACA), there was an increase in the incidence of early-stage breast and colorectal cancer, according to a research letter published online Nov. 2
Oncology April 20,2024
20 minutes of exercise can boost your brain after a bad night's sleep

20 minutes of exercise can boost your brain after a bad night's sleep

by University of PortsmouthCredit: Unsplash/CC0 Public DomainNew research has explored how sleep, oxygen levels, and exercise affect our ability to perform mental tasks.Sleep is fundamental in ma
Neurology April 20,2024
20 minutes of exercise can boost your brain after a bad night's sleep

20 minutes of exercise can boost your brain after a bad night's sleep

by University of PortsmouthCredit: Unsplash/CC0 Public DomainNew research has explored how sleep, oxygen levels, and exercise affect our ability to perform mental tasks.Sleep is fundamental in ma
Neurology April 20,2024
Early supper associated with lower risk of breast and prostate cancer

Early supper associated with lower risk of breast and prostate cancer

by Barcelona Institute for Global HealthEarly supper associated with breast and prostate cancer risk. Credit: ISGlobalHaving an early supper or leaving an interval of at least two hours before going t
Oncology April 20,2024
Early supper associated with lower risk of breast and prostate cancer

Early supper associated with lower risk of breast and prostate cancer

by Barcelona Institute for Global HealthEarly supper associated with breast and prostate cancer risk. Credit: ISGlobalHaving an early supper or leaving an interval of at least two hours before going t
Oncology April 20,2024
Two drugs are better than one in fight against leukaemia

Two drugs are better than one in fight against leukaemia

by FreshscienceDr Laura Eadie at work in the SAHMRI Leukaemia Research Laboratory. Credit: SAHMRIAdelaide scientists have devised a way to enhance the effectiveness of a patient's leukaemia treatm
Oncology April 20,2024
Two drugs are better than one in fight against leukaemia

Two drugs are better than one in fight against leukaemia

by FreshscienceDr Laura Eadie at work in the SAHMRI Leukaemia Research Laboratory. Credit: SAHMRIAdelaide scientists have devised a way to enhance the effectiveness of a patient's leukaemia treatm
Oncology April 20,2024
Rare but important gene target found in many tumor types, suggesting new therapy possible

Rare but important gene target found in many tumor types, suggesting new therapy possible

by Georgetown University Medical CenterStephen V. Liu, MD, an associate professor of medicine at Georgetown Lombardi Comprehensive Cancer Center. Credit: Georgetown UniversityA consortium of rese
Oncology April 20,2024
Rare but important gene target found in many tumor types, suggesting new therapy possible

Rare but important gene target found in many tumor types, suggesting new therapy possible

by Georgetown University Medical CenterStephen V. Liu, MD, an associate professor of medicine at Georgetown Lombardi Comprehensive Cancer Center. Credit: Georgetown UniversityA consortium of rese
Oncology April 20,2024
Early genome catastrophes can cause non-smoking lung cancer

Early genome catastrophes can cause non-smoking lung cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Smoking-unrelated oncogenesis of lung cancers by gene fusions. Credit: The Korea Advanced Institute of Science and Technology (KAI
Oncology April 20,2024
Early genome catastrophes can cause non-smoking lung cancer

Early genome catastrophes can cause non-smoking lung cancer

by The Korea Advanced Institute of Science and Technology (KAIST)Smoking-unrelated oncogenesis of lung cancers by gene fusions. Credit: The Korea Advanced Institute of Science and Technology (KAI
Oncology April 20,2024
An unexpected developmental hierarchy in an unusual disease

An unexpected developmental hierarchy in an unusual disease

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesLCH cells from a tumour biopsy, imaged with a confocal microscope. The green staining identifies the actively prolifer
Oncology April 20,2024
An unexpected developmental hierarchy in an unusual disease

An unexpected developmental hierarchy in an unusual disease

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesLCH cells from a tumour biopsy, imaged with a confocal microscope. The green staining identifies the actively prolifer
Oncology April 20,2024
Early removal of slow-growing brain tumors dramatically improves survival

Early removal of slow-growing brain tumors dramatically improves survival

by Chris Lane,University College LondonGlioma (in centre of image, at top of brainstem). Credit: Wikimedia CommonsA shift in surgical practice over the last decade towards the earlier removal of
Oncology April 20,2024
Early removal of slow-growing brain tumors dramatically improves survival

Early removal of slow-growing brain tumors dramatically improves survival

by Chris Lane,University College LondonGlioma (in centre of image, at top of brainstem). Credit: Wikimedia CommonsA shift in surgical practice over the last decade towards the earlier removal of
Oncology April 20,2024
Early palliative care offers no extra benefit for mesothelioma patients

Early palliative care offers no extra benefit for mesothelioma patients

by Curtin UniversityCredit: CC0 Public DomainEarly specialist palliative care treatment does not improve the quality of life for patients diagnosed with the rare cancer mesothelioma when compared
Oncology April 20,2024
Early palliative care offers no extra benefit for mesothelioma patients

Early palliative care offers no extra benefit for mesothelioma patients

by Curtin UniversityCredit: CC0 Public DomainEarly specialist palliative care treatment does not improve the quality of life for patients diagnosed with the rare cancer mesothelioma when compared
Oncology April 20,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com